• General healthcare issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Food and Drug Administration Act of 2007 (Public Law no. 110-85); Comparative Effectiveness Research Act (S.3408); American Recovery and Reinvestment Act of 2008 (Public Law No. 111-5); Health Reform; Affordable Healthcare for America Act (HR 3962); Patient Protection And Affordable Care Act (HR 3590); Affordable Health Choices Act (HR 3200); Drug Importation
• General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement; Physician Gifts; Physician Payments Sunshine Act (S.301); Medicare Part D; Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173)

Duration: January 1, 2006 to June 30, 2010

General Issues: Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

Spending: about $430,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2006: House of Representatives, U.S. Senate